RU2013152013A - Офтальмологическая композиция с системой увеличения вязкости, имеющей два различных увеличивающих вязкость агента - Google Patents

Офтальмологическая композиция с системой увеличения вязкости, имеющей два различных увеличивающих вязкость агента Download PDF

Info

Publication number
RU2013152013A
RU2013152013A RU2013152013/15A RU2013152013A RU2013152013A RU 2013152013 A RU2013152013 A RU 2013152013A RU 2013152013/15 A RU2013152013/15 A RU 2013152013/15A RU 2013152013 A RU2013152013 A RU 2013152013A RU 2013152013 A RU2013152013 A RU 2013152013A
Authority
RU
Russia
Prior art keywords
viscosity
composition according
ophthalmic composition
agent
composition
Prior art date
Application number
RU2013152013/15A
Other languages
English (en)
Russian (ru)
Inventor
Масуд А. ЧОВХАН
Малай ГХОШ
Original Assignee
Алькон Рисерч, Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Алькон Рисерч, Лтд. filed Critical Алькон Рисерч, Лтд.
Publication of RU2013152013A publication Critical patent/RU2013152013A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RU2013152013/15A 2011-04-22 2012-04-19 Офтальмологическая композиция с системой увеличения вязкости, имеющей два различных увеличивающих вязкость агента RU2013152013A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161478081P 2011-04-22 2011-04-22
US61/478,081 2011-04-22
PCT/US2012/034171 WO2012145460A2 (en) 2011-04-22 2012-04-19 Ophthalmic composition with a viscosity enhancement system having two different viscosity enhancing agents

Publications (1)

Publication Number Publication Date
RU2013152013A true RU2013152013A (ru) 2015-05-27

Family

ID=46025951

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2013152013/15A RU2013152013A (ru) 2011-04-22 2012-04-19 Офтальмологическая композиция с системой увеличения вязкости, имеющей два различных увеличивающих вязкость агента

Country Status (10)

Country Link
US (1) US20120269862A1 (cg-RX-API-DMAC7.html)
EP (1) EP2699228A2 (cg-RX-API-DMAC7.html)
JP (2) JP2014525891A (cg-RX-API-DMAC7.html)
KR (1) KR20140022900A (cg-RX-API-DMAC7.html)
CN (1) CN104039307A (cg-RX-API-DMAC7.html)
AU (1) AU2012245538B2 (cg-RX-API-DMAC7.html)
CA (1) CA2833591A1 (cg-RX-API-DMAC7.html)
MX (1) MX2013012307A (cg-RX-API-DMAC7.html)
RU (1) RU2013152013A (cg-RX-API-DMAC7.html)
WO (1) WO2012145460A2 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10174006B2 (en) * 2013-06-06 2019-01-08 Novartis Ag Topical aqueous ophthalmic compositions containing a 1H-indole-1-carboxamide derivative and use thereof for treatment of ophthalmic disease
RU2595837C2 (ru) * 2014-09-29 2016-08-27 Открытое Акционерное Общество "Татхимфармпрепараты" Состав и способ получения глазных капель
CN113366025A (zh) 2019-01-30 2021-09-07 鲍希与洛姆伯股份有限公司 交联的聚合物网络及其用途

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4027020A (en) 1974-10-29 1977-05-31 Millmaster Onyx Corporation Randomly terminated capped polymers
US3931319A (en) 1974-10-29 1976-01-06 Millmaster Onyx Corporation Capped polymers
US4407791A (en) 1981-09-28 1983-10-04 Alcon Laboratories, Inc. Ophthalmic solutions
US4525346A (en) 1981-09-28 1985-06-25 Alcon Laboratories, Inc. Aqueous antimicrobial ophthalmic solutions
US4836986A (en) 1984-09-28 1989-06-06 Bausch & Lomb Incorporated Disinfecting and preserving systems and methods of use
US5037647A (en) 1988-09-15 1991-08-06 Alcon Laboratories, Inc. Aqueous antimicrobial opthalmic solutions comprised of quaternary ammonium compound, citric acid, citrate and sodium chloride
US5145643A (en) 1990-01-05 1992-09-08 Allergan, Inc. Nonoxidative ophthalmic compositions and methods for preserving and using same
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
US5300287A (en) 1992-11-04 1994-04-05 Alcon Laboratories, Inc. Polymeric antimicrobials and their use in pharmaceutical compositions
DE69818675T2 (de) 1997-07-29 2004-07-29 Alcon Laboratories, Inc., Fort Worth Galaktomannanpolymere und borat enthaltende augenarzneimittel
US6174524B1 (en) * 1999-03-26 2001-01-16 Alcon Laboratories, Inc. Gelling ophthalmic compositions containing xanthan gum
JP5000835B2 (ja) * 2000-08-25 2012-08-15 千寿製薬株式会社 水性懸濁液剤
AR031135A1 (es) * 2000-10-10 2003-09-10 Upjohn Co Composiciones de antibiotico topico para el tratamiento de infecciones oculares
CA2839849C (en) * 2003-06-13 2017-03-07 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
JP4850513B2 (ja) * 2003-07-03 2012-01-11 株式会社メニコン 点眼用組成物
JP4963359B2 (ja) * 2005-01-12 2012-06-27 ロート製薬株式会社 眼局所適用製剤
CN101057966B (zh) * 2007-05-16 2011-04-13 中国科学院上海药物研究所 一种表皮生长因子眼用脂质纳米载体原位凝胶制剂
CN101073556A (zh) * 2007-06-25 2007-11-21 苏州瑞桥医药科技有限公司 一种散瞳眼用制剂及其制备方法
AU2009225931B9 (en) 2008-03-17 2014-04-03 Novartis Ag Aqueous pharmaceutical compositions containing borate-polyol complexes
CN101564374A (zh) * 2008-04-25 2009-10-28 北京和润创新医药科技发展有限公司 一种药物眼用即型凝胶
JP5731980B2 (ja) * 2008-10-09 2015-06-10 ラムズコア, インコーポレイテッド ドライアイ症候群の処置のための組成物および方法
US8501800B2 (en) * 2009-03-05 2013-08-06 Insite Vision Incorporated Controlled-release ophthalmic vehicles
TWI489997B (zh) 2009-06-19 2015-07-01 Alcon Res Ltd 含有硼酸-多元醇錯合物之水性藥學組成物

Also Published As

Publication number Publication date
AU2012245538B2 (en) 2017-06-15
KR20140022900A (ko) 2014-02-25
EP2699228A2 (en) 2014-02-26
CN104039307A (zh) 2014-09-10
MX2013012307A (es) 2014-01-31
AU2012245538A1 (en) 2013-10-17
CA2833591A1 (en) 2012-10-26
WO2012145460A3 (en) 2014-07-24
WO2012145460A2 (en) 2012-10-26
JP2014525891A (ja) 2014-10-02
JP2017088629A (ja) 2017-05-25
US20120269862A1 (en) 2012-10-25

Similar Documents

Publication Publication Date Title
CN102164592B (zh) 可与核黄素一起使用的增强剂制备用于在圆锥角膜的治疗中进行角膜交联的眼用组合物的用途以及相应眼用组合物
US8455494B2 (en) Preparations and methods for ameliorating or reducing presbyopia
JP7614069B2 (ja) ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物
ES2709101T3 (es) Lente de contacto de hidrogel humectable y método para la producción de la misma
WO2010135731A1 (en) Preparations and methods for ameliorating or reducing presbyopia
JP2015514751A5 (cg-RX-API-DMAC7.html)
JP2004262777A (ja) アセチル化ヒアルロン酸含有眼用医薬組成物
WO1996019211A1 (en) Liposome eye drops
RU2014140885A (ru) Фармацевтическая композиция ибупрофена и трамадола для офтальмологического применения
TW201722440A (zh) 淚液油層穩定劑及含有該淚液油層穩定劑的滴眼劑
JP2008024701A (ja) アルギン酸又はその塩を含有するソフトコンタクトレンズ用組成物
RU2011100108A (ru) Гелеобразующие in situ системы для пролонгированной доставки на переднюю часть глаза
US20180228902A1 (en) Pharmaceutical composition for administration to nasal mucosa
RU2013152026A (ru) Офтальмологическая композиция с повышающей вязкость системой, содержащей два различных средства повышения вязкости
EP3295932A3 (en) Stable odf composition containing hardly soluble therapeutic agent
JP2014210807A5 (cg-RX-API-DMAC7.html)
JP2014525891A5 (cg-RX-API-DMAC7.html)
CN103919717A (zh) 一种酒石酸溴莫尼定眼用凝胶制剂及其制备方法和用途
WO2015041193A1 (ja) 両性イオン性ソフトコンタクトレンズ用眼科用組成物
US9913840B2 (en) Formulations for aripiprazole delivery transdermally
I Tartara et al. New mucoadhesive polymeric film for ophthalmic administration of acetazolamide
AU2012245538B2 (en) Ophthalmic composition with a viscosity enhancement system having two different viscosity enhancing agents
JP2010106015A (ja) 点眼剤
KR20200080493A (ko) 효과 지속성 점안제 조성물
JP2006143590A (ja) 粘膜適用組成物

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20170912